logo

For the Inventor, By the Inventor

Cambridge, United Kingdom

Cambridge Antibody Technology Limited

USPTO Granted Patents = 28

% Expired Patents = 21.4



Forward Citations = 5,008

Loading Chart...
Loading Chart...

63 inventors (with patents filed for the assignee):

goldMedal Gregory Paul Winter (14 out of 75 patents)

silverMedal Kevin Stuart Johnson (14 out of 25 patents)

bronzeMedal John Gerald McCafferty (12 out of 30 patents)

4.  Andrew David Griffiths (11 out of 59 patents)

5.  Tristan J Vaughan (7 out of 33 patents)

6.  James David Marks (6 out of 81 patents)

7.  Alison Jane Wilton (5 out of 20 patents)

8.  Anthony Richard Pope (5 out of 13 patents)

9.  Jane Katharine Osbourn (5 out of 5 patents)

10.  Andrew John Smith (5 out of 5 patents)

11.  Elaine Joy Derbyshire (4 out of 10 patents)

12.  Andrew James Williams (4 out of 6 patents)

13.  Philip Ronald Tempest (4 out of 19 patents)

14.  Ronald Henry Jackson (4 out of 13 patents)

15.  Peter Michael Waterhouse (3 out of 23 patents)


Core Competencies:
Antibodies
Specific Binding Proteins
Eotaxin
Neutralizing Antibodies
Chimeric Antibodies
Ribosome Display
TGF-β2
GDF-8
Multivalent Binding Proteins
Recombinant Vectors
Antibody Segment Repertoires
Single Domain Ligands

28 patents:

1. 7495085 - Antibodies against human or mouse IL-21 receptor (2009-02-24),
2. 7368111 - Human antibodies specific for TGFβ2 (2008-05-06),
3. 7323311 - Methods of obtaining a specific binding member that binds eotaxin (2008-01-29),
4. 7306907 - Single domain ligands, receptors comprising said ligands, methods for their production, and use of said ligands and receptors (2007-12-11),
5. 7261893 - Neutralizing antibodies against GDF-8 and uses therefor (2007-08-28),
6. 7195866 - Production of anti-self antibodies from antibody segment repertoires and displayed on phage (2007-03-27),
7. 7151169 - [object Object] (2006-12-19),
8. 7074557 - Ribosome display (2006-07-11),
9. 7063943 - Methods for producing members of specific binding pairs (2006-06-20),
10. 6946546 - Human antibodies against eotaxin (2005-09-20),
11. 6916605 - Methods for producing members of specific binding pairs (2005-07-12),
12. 6827925 - Specific binding proteins including antibodies which bind to the necrotic center of tumors, and uses thereof (2004-12-07),
13. 6492497 - Specific binding members for TGFbeta1 (2002-12-10),
14. 6489123 - Labelling and selection of molecules (2002-12-03),
15. 6342588 - Labelling and selection of molecules (2002-01-29),
Company Overview
Cambridge Antibody Technology Limited is a biotechnology company based in Cambridge, UK, specializing in the development of therapeutic antibodies. The organization focuses on innovative solutions for various diseases, leveraging advanced technologies in antibody engineering and discovery. With a strong emphasis on research and development, the company collaborates with partners in the pharmaceutical industry to bring novel treatments to market, enhancing patient care through targeted therapies.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Cambridge Antibody Technology Limited USPTO Patent Assignee Logo
28 Patents

#39 in Cambridge

#637 in United Kingdom

#23,299 in the World

Cambridge, GB
Cambridge, United Kingdom

Cambridge Antibody Technology Limited

Forward Citations = 5,008

63 inventors:

goldMedal Gregory Paul Winter (14 out of 75 patents)

silverMedal Kevin Stuart Johnson (14 out of 25 patents)

bronzeMedal John Gerald McCafferty (12 out of 30 patents)

4.  Andrew David Griffiths (11 out of 59 patents)

5.  Tristan J Vaughan (7 out of 33 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Cambridge Antibody Technology Limited. Retrieved from https://idiyas.com/company/cambridge-antibody-technology

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…